Lynne Parshall, Director at Foghorn Therapeutics, holds ― shares in Foghorn Therapeutics (Ticker: FHTX), holds 51.34K shares in Ionis Pharmaceuticals (Ticker: IONS), holds ― shares in Akcea Therapeutics (Ticker: AKCA). Most recently, Lynne Parshall ― shares of Foghorn Therapeutics on ― for an estimated value of ―.
Lynne Parshall latest transaction was an Uninformative Buy of ―.
What was Lynne Parshall's most profitable transaction?
Lynne Parshall’s most profitable transaction was an Informative Sell of CYTK stock on August 12, 2024. The return on the trade was 38.90%.
What is Lynne Parshall's role in Foghorn Therapeutics?
Lynne Parshall's role in Foghorn Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.